期刊文献+

丹参酮ⅡA自纳米乳的制备及其质量的评价 被引量:3

Preparation and quality evaluation of tanshinone ⅡA self nano emulsifying drug delivery system
原文传递
导出
摘要 目的研制丹参酮ⅡA自纳米乳来增加药物的溶出率。方法采用伪三元相图法,以乳剂外观、粒径、Zeta电位为指标优选处方,采用HPLC测定丹参酮ⅡA,考察其药剂学特性。结果优选处方为Tween80-PEG400-MCT(31∶62∶7),载药量1.5 mg·m L-1,平均粒径42.63±1.80 nm,多分散系数PDI为0.16±0.037,Zeta电位为-12.35±0.96 m V。以0.5%Tween80为溶出介质,丹参酮ⅡA自纳米乳在1.5 h时的累积释药量即可达载药量的55%。结论丹参酮ⅡA自纳米乳可显著提高药物的溶出速率。 OBJECTIVE To develope tanshinone Ⅱ A (Tan Ⅱ A) self nano emulsifying drug delivery system to increase the drug dissolution rate. METHODS The formulation optimization was performed by Pseudo - ternary phase diagram and evaluated by the physical appearance,mean particle size and Zeta potential. An HPLC method was applied to determine Tan Ⅱ A to characterize the developed drug delivery system. RESULTS The optimized formulation composed of Tween80 - PEG400 - MCT (31 : 62 : 7 ). In optimized formulation, the drug loading was 1.5 mg· mL^- 1 , and the mean particle size was 42.63 ± 1.80 nm, and the Zeta potential was - 12.35 ± 0.96 mV and the PDI was 0.16 ± 0. 037. The cumulative amount of drug release from the self nano emulsifying drug delivery system reached 55% of the drug loading in 1.5 hours when 0.5% Tween80 was served as dissolution medium. CONCLUSION The developed self - emulsifying nano emulsion formulation can increase the dissolution rate of Tan Ⅱ A.
出处 《华西药学杂志》 CAS CSCD 2015年第2期143-145,共3页 West China Journal of Pharmaceutical Sciences
关键词 丹参酮ⅡA 自乳化 溶出速率 质量评价 伪三元相图法 高效液相色谱法 Tanshinone Ⅱ A Self - emulsifvin Drug delivery system Quality evaluation : Pseudo - ternary phase diagram: HPLC
  • 相关文献

参考文献9

  • 1袁淑兰,宋毅,王修杰,张洁.丹参酮ⅡA抑制多种肿瘤细胞生长的体外实验研究[J].华西药学杂志,2003,18(5):327-329. 被引量:43
  • 2梁臻,毛声俊,尹宗宁,金辉,吴宇,储婷.丹参酮Ⅱ_A与丹参酮Ⅱ_A磺酸钠在小鼠体内的分布[J].华西药学杂志,2008,23(4):416-419. 被引量:4
  • 3Wang L, Jiang X, Xu W, et al. Complexation of tanshinone II A with 2 - hydroxypropyl - 13 - cyclodextrin : effect on aqueous solu- bility, dissolution rate and intestinal absorption behavior in rat [ J ]. Int J Pharm ,2007,341 ( 1 - 2 ) :58 - 67.
  • 4Hao H,Wang G, Cui N, et al. Identification of a novel intestinal first pass metabolic pathway: NQO1 mediated quinone reduction and subsequent glucuronidation [ J ]. Curr Drug Metba, 2007,8 (2) :137 -149.
  • 5Neslihan GR, Simon B. Self - emulsifying drug delivery systerms (SEDDS) for improved oral delivery of lipophilic drugs [ J ]. Bio- medicine & Pharmacotherapy ,2004,58 ( 3 ) : 173 - 182.
  • 6Shah NH, Carvajal MT, Patel CI, et al. Self - emulsifying drug delivery systems (SEDDS) with polyglycolyzed glycerides for improving in vitro dissolution and oral absorption of lipophilic drug[ J]. Int J Pharm, 1994,106 ( 1 ) : 15 - 23.
  • 7Wei YH, Ye XL, Shang XG, et al. Enhanced oral bioavailability of Silybin by a supersaturatable self - emulsifying dru gdelivery sys- tem( S -SEDDS) [J]. Colloids Surfaces A: Physicochem Eng Aspects,2012,396:22 - 28.
  • 8Nazzal S, Smalyukh II, Lavrentovich OD ,et al. Preparation and in vitro characterization of a eutectic based semisolid self - nanoe- mulsified drug delivery system(SNEDDS) of ubiquinone:Mecha- nis mand progress of emulsion formation [ J ]. Int J Pharm, 2002, 235( 1 -2) :247 -265.
  • 9栾长涛,孙逊,袁志翔,龚涛,张志荣.康普瑞丁自乳化药物传递系统的筛选及质量评价[J].华西药学杂志,2010,25(1):9-12. 被引量:2

二级参考文献14

  • 1刘艾林,李铭源,王一涛,杜冠华.丹参药理学活性物质基础研究现状[J].中国药学杂志,2007,42(9):641-646. 被引量:155
  • 2West CmL, Price P. Combretastatin A4 phos phate [ J ]. Anti Cancer Drugs,2004,15(3) :179 - 187.
  • 3Jeremy G, James M, Robin H. Targeting tumour vasculture: the development of combretastatin A4 [J]. Oncology, 2001,2 ( 2 ) : 83 - 87.
  • 4Kommuru TR, Gurley B, Khan MA, et al. Self emulsifying drug delivery systems ( SEDDS ) of coenzyme Q10 : formulation development and bioavailability assessment[ J ]. Int J Pharm,2001,212 (2) :233 -246.
  • 5Ping Li, Anasuya G, Robert F, et al. Eeffet of combined use of nonionic surfactant on formation of oil in water microemulsions [J]. Int J Phann ,2004,173 : 155 - 164.
  • 6刘传贵,王福文,李振伟.HPLC测定血栓心脉宁片中丹参酮Ⅱ_A和丹酚酸B的含量[J].中国现代中药,2007,9(8):12-14. 被引量:4
  • 7钱名堃,杨保津,顾文华,陈政雄,陈馨德,叶秀琴.丹参有效成分的研究--Ⅰ.丹参酮Ⅱ-A 磺酸钠和次甲丹参醌的化学结构[J]化学学报,1978(03).
  • 8金辉,毛声俊,梁臻,吴宇.一种含丹参酮ⅡA磺酸钠的药用组合物及其质量控制方法[P]中国专利:CN1686103.
  • 9宋笑丹,唐景玲,吴琳华.自乳化释药系统的研究进展[J].中国医院药学杂志,2008,28(22):1954-1956. 被引量:2
  • 10何应金,张洁,刘静,何雯雯,周莎,田信,徐小平.Combretastatin A4磷酸酯二钠在大鼠体内的药物动力学[J].华西药学杂志,2008,23(6):663-665. 被引量:7

共引文献46

同被引文献11

引证文献3

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部